Decoding Recurrence in Early-Stage and Locoregionally Advanced Non–Small Cell Lung Cancer: Insights From Electronic Health Records and Natural Language Processing
JCO Clinical Cancer Informatics · 2025-04 · (9)
DOI: 10.1200/cci-24-00227 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Clinical Cancer Informatics, 2025-04. Verfasst von Kyeryoung Lee und 9 weiteren Autor:innen. Beteiligte Einrichtung: GeneDx (Sema4), Stamford, CT. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Electronic Health Records, Natural Language Processing, Lung Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
PURPOSE Recurrences after curative resection in early-stage and locoregionally advanced non–small cell lung cancer (NSCLC) are common, necessitating a nuanced understanding of associated risk factors. This study aimed to establish a natural language processing (NLP) system to efficiently curate recurrence data in NSCLC and analyze risk factors longitudinally. PATIENTS AND METHODS Electronic health records of 6,351 patients with NSCLC with >700,000 notes were obtained from Mount Sinai's data sets. A deep learning–based customized NLP system was developed to identify cohorts experiencing recurrence. Recurrence types and rates over time were stratified by various clinical features. Cohort description analysis, Kaplan-Meier analysis for overall recurrence-free survival (RFS) and distant metastasis-free survival (DMFS), and Cox proportional hazards analysis were performed. RESULTS Of 1,295 patients with stage I–IIIA NSCLC with surgical resections, 336 patients (25.9%) experienced recurrence, as identified through NLP. The NLP system achieved a precision of 94.3%, a recall of 93%, and an F1 score of 93.5. Among 336 patients, 52.4% had local/regional recurrences, 44% distant metastases, and 3.6% unknown recurrence. RFS rates at years 1-5 were 93%, 81%, 73%, 67%, and 61%, respectively (96%, 89%, 84%, 80%, and 75% for distant metastasis). Stage-specific RFS rates at year 5 were 73% (IA), 62% (IB), 47% (IIA), 46% (IIB), and 20% (IIIA). Stage IB patients had a significantly higher likelihood of recurrence versus stage IA (adjusted hazard ratio [aHR], 1.63; P = .02). The RFS was lower in patients with clinically significant TP53 alteration ( v TP53 -negative or unknown significance), affecting overall RFS (aHR, 1.89; P = .007) and DMFS (aHR, 2.47; P = .009) among stage IA/IB patients. CONCLUSION Our scalable NLP system enabled us to generate real-world insights into NSCLC recurrences, paving the way for predictive models for preventing, diagnosing, and treating NSCLC recurrence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- GeneDx (Sema4), Stamford, CT.
- Lung Cancer Initiative, Johnson & Johnson, New Brunswick, NJ.
- Icahn School of Medicine at Mount Sinai, New York, NY.
- Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX.
ORCID-Profile: Kyeryoung Lee, Zongzhi Liu, Qing Huang, David Corrigan, Iftekhar Kalsekar, Tomi Jun, Gustavo Stolovitzky, William K Oh
Zitieren
APA
Lee, K., Liu, Z., Huang, Q., Corrigan, D., Kalsekar, I., Jun, T., Stolovitzky, G., Oh, W. K., Rajaram, R., & Wang, X. (2025). Decoding Recurrence in Early-Stage and Locoregionally Advanced Non–Small Cell Lung Cancer: Insights From Electronic Health Records and Natural Language Processing. JCO Clinical Cancer Informatics. https://doi.org/10.1200/cci-24-00227
Vancouver
Lee K, Liu Z, Huang Q, Corrigan D, Kalsekar I, Jun T, et al. Decoding Recurrence in Early-Stage and Locoregionally Advanced Non–Small Cell Lung Cancer: Insights From Electronic Health Records and Natural Language Processing. JCO Clinical Cancer Informatics. 2025. doi:10.1200/cci-24-00227
BibTeX
@article{Lee2025,
author = {Lee, Kyeryoung and Liu, Zongzhi and Huang, Qing and Corrigan, David and Kalsekar, Iftekhar and Jun, Tomi and Stolovitzky, Gustavo and Oh, William K and Rajaram, Ravi and Wang, Xiaoyan},
title = {Decoding Recurrence in Early-Stage and Locoregionally Advanced Non–Small Cell Lung Cancer: Insights From Electronic Health Records and Natural Language Processing},
journal = {JCO Clinical Cancer Informatics},
year = {2025},
number = {9},
doi = {10.1200/cci-24-00227}
}
EUVIMED